Log in
Enquire now
‌

US Patent 11351143 Methods of treating amyotrophic lateral sclerosis

Patent 11351143 was granted and assigned to Retrotope Inc. on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Retrotope Inc.
Retrotope Inc.
Current Assignee
Retrotope Inc.
Retrotope Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11351143
Date of Patent
June 7, 2022
Patent Application Number
17169271
Date Filed
February 5, 2021
Patent Citations Received
‌
US Patent 12109194 Synergistic combination therapy for treating ALS
0
‌
US Patent 11510889 Methods for inhibiting the progression of neurodegenerative diseases
‌
US Patent 11491130 Methods of treating amyotrophic lateral sclerosis
Patent Primary Examiner
‌
Jeffrey S Lundgren

Disclosed are methods for inhibiting the progression of Amyotrophic Lateral Sclerosis (ALS). The methods include administering to a patient suffering from ALS a composition comprising either deuterated linoleic acid or an ester or deuterated arachidonic acid or an ester thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11351143 Methods of treating amyotrophic lateral sclerosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.